Positioning Horlicks As 'Superior To Food' Lands GSK In Hot Water In India
Executive Summary
GSK has been reprimanded by India's ad regulator for “exaggerating the concept of bioavailability as a gimmick” in an online promotion for its Horlicks brand. Separately, Reckitt Benckiser has been admonished for breaching ad rules in two consumer health brand campaigns.
You may also be interested in...
Horlicks Brings Unilever 'Transformative' Nutritional Deal, Market Challenges
Firm's Hindustan Unilever division will merge with s GSK Consumer Healthcare India which has had total sales around €550m so far in 2018, primarily through the Horlicks and Boost brands and with nearly 90% of the revenues in India. Also will acquire 82% stake in GSK Bangladesh and other GSK commercial operations and assets outside India, paying €3.3bn in combination of cash and shares in Hindustan Unilever.
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
Norway's Orkla Prioritizes Seeing Off Private-Label Consumer Health Challenge
Alongside addressing the threat posed by private-label, Orkla Health CEO Isabelle Ducellier will over the coming three years focus on building global brands and simplifying the value chain to improve efficiency and extract synergies.